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Effect of rutin from tartary buckwheat sprout on serum 
glucose-lowering in animal model of type 2 diabetes
This study investigates the anti-diabetic effects 
of rutin from tartary buckwheat sprout in type 
2 diabetes mouse model. The rutin content in 
tartary buckwheat sprout (TBS) is five times 
higher than that found in common buckwheat 
sprout (CBS) as evident from high-performance 
liquid chromatography analysis. Administra-
tion of either rutin or TBS ethanolic extract to 
diabetes mice decreased the serum glucose 
level significantly. Rutin down-regulated the 
expression levels of protein-tyrosine phospha-
tase 1B; it is negative regulator of insulin path-
way, both transcriptionally and translationally 
in myocyte C2C12 in a dose-dependent manner. 
In conclusion, rutin can play a critical role in 
down-regulation of serum glucose level in type 
2 diabetes.
Keywords: tartary buckwheat sprout, rutin, type 
2 diabetes, insulin signaling
Buckwheat is a nutritious and pharmaceutically important plant. It contains valuable 
components that protect human health against inflammation and carcinogenesis (1). 
Among the main components, rutin, namely rutoside, flavonoid glycoside, is one of the 
most abundant polyphenols in tartary buckwheat (2). In particular, the amount of rutin 
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been well known in the management of diabetes mellitus. So far, the antidiabetic effect of 
 buckwheat was attributed to D-chiro inositol as a source of insulin mediator in buckwheat 
seed bran (3). In addition, the seed of tartary buckwheat was reported to improve high 
glucose-induced insulin resistance and diabetes in mice (4). Protein-tyrosine phosphatase 
1B (PTP1B) is known to be a negative regulator of the insulin signaling pathway. Increased 
expression of PTP1B can regulate the downstream insulin signal transduction, leading to 
the inhibition of glucose uptake and glycogen synthesis (5). However, there are only few 
studies about rutin from buckwheat sprouts against diabetes. Thus, we focused on the 
antidiabetic effects of rutin from tartary buckwheat sprout. The purpose of the present 
study was to investigate whether the administration of either tartary buckwheat sprout 
ethanol extract or rutin lowered the serum glucose levels in vivo. In addition, we examined 
the mechanism of action of rutin with the target gene expression involved in insulin sig-
naling in preadipocyte and myocyte cell lines by reverse transcriptase-polymerase chain 
reaction (RT-PCR) and immunoblot analysis.
EXPERIMENTAL
Materials
Common buckwheat sprout (CBS) (Fagopyrum esculentum) and tartary buckwheat sprout 
(TBS) (Fagopyrum tartaricum) were obtained from the farm of the Chungbuk National Uni-
versity (Cheongju, Republic of Korea). Rutin (purity ≥ 95 %), isoorientin, vitexin, isovitexin 
and quercetin were purchased from Sigma (USA). Mouse cell lines 3T3-L1 and C2C12 were 
obtained from the American Type Culture Collection (USA). Male C57BL/6J and diabetes 
C57BL/6J (B6.Cg-m+/+Leprdb/J) mice were kindly provided by the Korea Research Institute of 
Bioscience and Biotechnology (Republic of Korea). C57BL/6J mouse is a common inbred 
strain with a dark brown coat. The homozygous spontaneous mutation (B6.Cg-m+/+Leprdb/J) 
was used for diabetes mouse (db/db mouse). Mice were fed a normal diet ad libitum and were 
kept in a temperature- and humidity-controlled standard animal house cage with 12 hour 
light/dark cycle. Animal treatment was approved by the animal care protocol of the Korea 
Basic Science Institute (Daejeon, Republic of Korea) review committee.
Analysis of phenolic compounds from buckwheat sprouts
Extraction of buckwheat sprouts and analysis of phenolic compounds from CBS and 
TBS were performed as described previously (6). Standard chemicals such as rutin, isoori-
entin, vitexin, isovitexin and quercetin were applied under the same high-performance 
liquid chromatography (HPLC) conditions, and the retention times of buckwheat sprout 
extract components were compared to those of the standards.
Intravenous glucose tolerance test
Tester control and db/db mice were fasted overnight. For intravenous glucose tolerance 
test, rutin (1 mg) or TBS extract (10 mg) was dissolved in 25 µL dimethyl sulfoxide (5 %, 
V/V) and 75 µL of distilled water added to dimethyl sulfoxide dilution. The solution of 
rutin (1 mg per 100 µL or 10 mg per µL TBS) was administered to the oral cavity 2 hours 
before glucose injection (n = 3). The first blood sample was collected from the tail vein at 
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the start time (0 min) and, immediately, a 5 % glucose solution (2 g per kg body mass) was 
injected to the tail vein. Blood was consecutively collected every 30 min up to 180 min. 
Serum glucose level was assessed using a portable glucose oxidase digital assay kit (LifeS-
can, Johnson & Johnson, USA).
Cell culture, reverse-transcriptase PCR and immunoblot analyses
Mouse preadipocyte (3T3-L1) and myocyte cell line (C2C12) were planted into 6-well 
plates and maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10 % (V/V) fetal bovine serum at 37 °C in a 5 % (V/V) CO2 incubator. Cultured cells 
were pretreated with rutin (100 and 250 mmol L–1). After one-day treatment, the cell 
growth was stopped and total RNA was isolated with TriZol (Invitrogen, USA) and RNase-
free DNase (Takara, Japan), according to the manufacturers’ instructions. The total RNA 
quantification and cDNA synthesis were performed as described previously (7). The rela-
tive mRNA expression level of protein tyrosine phosphatase 1B (PTP1B) was examined 
with a specific primer pair (sense: 5’-TGG GAA CTG GGC GGC TAT TAC-3’, antisense: 5’-
TCC ACT GAT CCT GCA CTG ACG AG-3’). The primer for glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) (sense: 5’-CAT CTC TGC CCC CTC TGC T-3’, antisense: 5’-ACG 
CCT GCT TCA CCA CCT T-3’) was used as internal control. Protein expression was exam-
ined by immunoblot analysis according to Hwang et al. (8). Protein concentrations of cell 
lysates were quantified using a bicinchoninic acid protein assay kit (Thermo Fisher Scien-
tific, USA) employing bovine serum albumin as the standard according to the manufac-
turer’s instructions. An equal amount of total protein (30 µg) was separated by 12 % so-
dium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a 
nitrocellulose membrane. The membrane was subsequently incubated with a primary an-
tibody against PTP1B (#5311, Cell Signaling Technology, USA) or/and anti-GAPDH (#SC-
25778, Santa Cruz Biotechnology, USA) as internal control at the dilution level of 1:4,000 
overnight. Horseradish peroxidase conjugated-goat anti-rabbit IgG secondary antibody 
was used for immunodetection at the dilution level of 1:2,000 or 1:8,000 for PTP1B and 
GAPDH, respectively. The immunoblot signals were detected using enhanced chemilumi-
nescence (Millipore, USA) and visualized on X-ray films (Kodak, USA)
RESULTS AND DISCUSSION
Phenolic compounds in the ethanol extracts of CBS and TBS were analyzed by reverse 
phase-HPLC as described previously (9). The chromatograms of CBS and TBS extracts are 
shown in Fig. 1. Several phenolic compounds, such as isoorientin (tR = 25 min), vitexin (tR = 28 
min) and isovitexin (tR = 32 min) were identified in CBS besides rutin (tR = 30.5 min) and quer-
cetin (tRT = 43 min) whereas rutin (tR = 31 min) was predominantly observed in TBS. The chro-
matogram patterns of buckwheat flavonoids were very similar to the previous report (5). The 
content of rutin in CBS and TBS was 11 mg and 50 mg per gram dry mass, respectively. Thus, 
the amount of rutin in TBS was approximately 5 times higher than that in CBS. Highly con-
centrated rutin in buckwheat leaves was in good agreement with other plant parts (10, 11).
To evaluate the lowering effects of serum glucose after oral administration, either 
rutin (1 mg per 100 µL) or TBS extract (10 mg per 100 µL) was applied to the control and db/
db mice, followed by detection of the serum glucose level. As shown in Figs. 2a and b, the 
oral pre-treatment with rutin showed no significant difference at time 0, whereas rutin 
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suppressed the serum glucose level after 30 min (p < 0.05). Rutin extract gradually de-
creased serum glucose level in db/db mice after oral administration (Fig. 2b). When TBS was 
applied to control mice, the serum glucose level decreased compared to the control group 
within 60 min (Fig. 2a) (p < 0.05). In db/db mice, pre-treatment with TBS showed a similar 
effect as that of rutin up to 120 min (Fig. 2b) (p < 0.05). This result indicates that rutin has 
the capacity of serum glucose level lowering, and is suggested as a therapeutic compound 
in type 2 diabetes. Likewise, an insulin mediator, D-chiro-inositol abundant in buckwheat, 
was reported to reduce the serum glucose level in type 1-diabetic rats (3). However, this 
direct effect of rutin from tartary buckwheat sprouts against type 2 diabetes was not ad-
dressed in the glucose tolerance test.
Fig. 1. HPLC chromatogram of ethanol extracts from: a) CBS and b) TBS.
Fig. 2. Intravenous glucose tolerance test in: a) control and b) db/db mice (mean ± SD, n = 3), *p < 0.05.
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To explore the action mode of rutin in insulin signaling, the gene expression of PTP1B 
in preadipocyte 3T3-L1 and myocyte C2C12 was examined. Under rutin treatment, the 
mRNA levels of PTP1B in both cell lines were clearly decreased in a dose-dependent man-
ner, as shown in Fig. 3a. In addition, the protein levels of PTP1B were not so much changed 
in 3T3-L1 but clearly decreased as the concentration of rutin increased to 250 mmol L–1 in 
C2C12 (Fig. 3b). These results suggest that the treatment with rutin activates the insulin 
receptor downstream signaling by suppressing transcriptionally and translationally the 
expression of PTP1B. The down-regulation of PTP1B by rutin may improve the insulin 
resistance and prevent the type 2 diabetic progression in skeletal muscle. Likewise, rutin 
from buckwheat could preserve the insulin secretory machinery and stimulate the insulin 
receptor substrate 2 signaling and AMP-kinase in rat pancreatic beta cells (12).
CONCLUSIONS
Biochemical analysis of serum glucose lowering by rutin was investigated in in vivo 
and in vitro systems. The serum glucose levels were decreased after 30 min by rutin pre-
treatment in db/db mice. The rise of serum glucose levels was suppressed in normal mice 
by rutin pre-treatment at the early time stage (30 min). When the pre-treatment of TBS 
extract was applied to the mice, the ability to decrease the serum glucose level was similar 
to that of rutin for both normal and diabetes mice. mRNA and protein expression of PT-
P1B, which is known as negative regulator of insulin receptor signaling pathway, were 
inhibited in myocyte-derived C2C12 cell by rutin treatment in a dose-dependent manner. 
Rutin is an effective compound for lowering serum glucose concentrations, which contrib-
utes to the regulation of the insulin signaling pathway in type 2 diabetes mellitus.
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Codes and acronyms. – 3T3-L1 – mouse preadipocyte cell line, AMP – adenosine monophosphate, 
C2C12 – mouse myoblast cell line, CBS – common buckwheat sprout, db/db mouse, diabetes mouse, 
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RT-PCR – reverse transcriptase-polymerase chain reaction, TBS – tartary buckwheat sprout.
Fig. 3. a) mRNA and b) protein expression of protein tyrosine phosphatase 1B (PTP1B) in 3T3-L1 and 
C2C12.
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